CN102068554A - Oral medicament special for treating osteoproliferation - Google Patents

Oral medicament special for treating osteoproliferation Download PDF

Info

Publication number
CN102068554A
CN102068554A CN2010106121389A CN201010612138A CN102068554A CN 102068554 A CN102068554 A CN 102068554A CN 2010106121389 A CN2010106121389 A CN 2010106121389A CN 201010612138 A CN201010612138 A CN 201010612138A CN 102068554 A CN102068554 A CN 102068554A
Authority
CN
China
Prior art keywords
parts
radix
herba
medicine
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010106121389A
Other languages
Chinese (zh)
Inventor
敖炼鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010106121389A priority Critical patent/CN102068554A/en
Publication of CN102068554A publication Critical patent/CN102068554A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides an oral medicament special for treating osteoproliferation. The oral medicament comprises the following active ingredients of: main ingredients including eucommia, safflower, large-fruited mucuna, epimedium herb, isatis root, costustoot, white paeony root, achyranthis bidentatae, cynomorium songaricum, scrophularia ningpoensis, lycopodium clavatum, Chinese angelica, rhizoma corydalis, pawpaw, lonicera, phellodendron, herba pyrolae, peach kernel, hematoxylon, semen cuscutae, teasel root and the like, and an auxiliary ingredient of pure water. The oral medicament is prepared by the following steps of: crushing the traditional Chinese medicines into powder, uniformly mixing the powder and water, preparing into pills, drying the pills and packaging for later use. The medicament is taken with tepid water three times a day according to the advice of a doctor; the medicament has outstanding effects on hyperplasia diseases, such as lubar intervertebral disc protrusion, osteoproliferation, ischioneuralgia and the like, and can effectively catalyze bony spurs and relieve pains; the diseases cannot reappear after being cured; and the pure traditional Chinese medicinal components have no side effect, so the oral medicament is an optimal selection for old patients.

Description

A kind of special for treating hyperosteogeny take medicine
Technical field
The present invention relates to a kind of medicine of taking of special for treating hyperosteogeny, particularly a kind of is the medicine of taking in order to the special for treating hyperosteogeny that raw material is made with Chinese medicine.
Background technology
Existing health preserving, cure the disease, the medicine majority of watch box is based on Western medicine, but the hormone composition ratio in the Western medicine is higher, the general designation special effect medicine, but this quasi drugs majority is to control table not control root, not strong to the disease steadiness after the treatment, can only separate interim misery so most of patients all reflects, can not get effecting a radical cure effect, and take this type of specially good effect Western medicine for a long time, health is done harm rather than good, stronger side effect is arranged, and taking for a long time and dose is increased successively can be effective, but finally still can not cure.
 
Summary of the invention
The medicine of taking that the purpose of this invention is to provide a kind of special special for treating hyperosteogeny.This pill all has the suitability to a series of causes of disease of bone matrix hyperplasia, to chronic and acute sick evident in efficacy, directly catalysis bony spur, play the effect of never recurrence and have no side effect.
Medicine of the present invention is a kind of medicine of taking of special for treating hyperosteogeny, this medicine is made by following pharmaceutical composition, and each drug dose is by weight being made up of following raw material: Cortex Eucommiae 15-25 part, Flos Carthami 15-25 part, Caulis seu Radix Schisandrae Henryi 20-30 part, sheep is closed 20-30 part, Radix Isatidis 20-30 part, Radix Aucklandiae 15-25 part, Radix Paeoniae Alba 15-25 part, cattle sunset 15-25 part, Herba Cynomorii 15-25 part, Radix Scrophulariae 15-25 part, Herba Lycopodii 15-25 part, Radix Angelicae Sinensis 15-25 part, Rhizoma Corydalis 15-25 part, Fructus Chaenomelis 20-30 part, Flos Lonicerae 20-30 part, Cortex Phellodendri 15-25 part, Herba Pyrolae 30-40 part, Semen Persicae 15-25 part, Lignum Sappan 15-25 part, Semen Cuscutae 20-30 part, Radix Dipsaci 15-25
Part etc.; Adjuvant is pure water 25%-30%;
Now all aforementioned pharmaceutical compositions composition scales well are ground into powdery again, that gets is standby; The pharmaceutical composition powder that above-mentioned title is got ready stirs evenly with pure water again, makes pill when treating the adhesion state again, packages spare after the oven dry.
As preferably, each weight ratio of organizing pharmaceutical composition is as follows:
20 parts of the Cortexs Eucommiae, 20 parts on Flos Carthami, 25 parts of Caulis seu Radix Schisandrae Henryi, sheep are closed 25 parts, 25 parts of Radix Isatidis, 20 parts of the Radix Aucklandiae, 20 parts of the Radix Paeoniae Albas, 20 parts of cattle sunset, 20 parts of Herba Cynomoriis, 20 parts of Radix Scrophulariaes, 20 parts of Herba Lycopodiis, 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Corydalis, 25 parts of Fructus Chaenomeliss, 25 parts of Flos Lonicerae, 20 parts of Cortex Phellodendris, 35 parts of Herba Pyrolaes, 20 parts in Semen Persicae, 20 parts of Lignum Sappans, 25 parts of Semen Cuscutae, 20 parts of Radix Dipsacis; Adjuvant is a pure water 30%.
The pill made of Chinese medicine thus, to acute disease pain relieving immediately, be not with the hormone composition, do not have side effects, the function of catalysis bony spur is had positive effect, can effectively cure hyperosteogeny, and after getting well, be difficult for recurrence, the consolidation effect is also quite strong, and prolapse of lumbar intervertebral disc is had obvious effect, has no side effect.The ball that takes this medicine is obviously felt in catalysis bony spur, alleviation misery, improvement sleep, is improved the colour of skin, the raising mental status after 7 days, only needed just can cure in 15 days to slight hyperosteogeny, only needed 45 days just can only need just can heal entirely in 90 days serious hyperosteogeny to the moderate hyperosteogeny.
 
The specific embodiment
A kind of special for treating hyperosteogeny of the present invention take medicine, each drug dose is by weight being made up of following raw material: Cortex Eucommiae 15-25 part, Flos Carthami 15-25 part, Caulis seu Radix Schisandrae Henryi 20-30 part, sheep is closed 20-30 part, Radix Isatidis 20-30 part, Radix Aucklandiae 15-25 part, Radix Paeoniae Alba 15-25 part, cattle sunset 15-25 part, Herba Cynomorii 15-25 part, Radix Scrophulariae 15-25 part, Herba Lycopodii 15-25 part, Radix Angelicae Sinensis 15-25 part, Rhizoma Corydalis 15-25 part, Fructus Chaenomelis 20-30 part, Flos Lonicerae 20-30 part, Cortex Phellodendri 15-25 part, Herba Pyrolae 30-40 part, Semen Persicae 15-25 part, Lignum Sappan 15-25 part, Semen Cuscutae 20-30 part, Radix Dipsaci 15-25 part etc.; Adjuvant pure water 25%-30%.
Manufacture method is: now all aforementioned pharmaceutical compositions composition scales well are ground into powdery again, that gets is standby; The pharmaceutical composition powder that above-mentioned title is got ready stirs evenly with pure water again, makes pill when treating the adhesion state again, packages spare after the oven dry.
In the present embodiment, the weight ratio of each pharmaceutical composition of taking medicine of this a kind of special for treating hyperosteogeny is as follows:
20 parts of the Cortexs Eucommiae, 20 parts on Flos Carthami, 25 parts of Caulis seu Radix Schisandrae Henryi, sheep are closed 25 parts, 25 parts of Radix Isatidis, 20 parts of the Radix Aucklandiae, 20 parts of the Radix Paeoniae Albas, 20 parts of cattle sunset, 20 parts of Herba Cynomoriis, 20 parts of Radix Scrophulariaes, 20 parts of Herba Lycopodiis, 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Corydalis, 25 parts of Fructus Chaenomeliss, 25 parts of Flos Lonicerae, 20 parts of Cortex Phellodendris, 35 parts of Herba Pyrolaes, 20 parts in Semen Persicae, 20 parts of Lignum Sappans, 25 parts of Semen Cuscutae, 20 parts of Radix Dipsacis; Adjuvant is a pure water 30%.
Instructions of taking and curative effect: this medicinal warm water delivery service, three times on the one, take according to doctor's advice; This medicine is to the sick highly significant of hypertrophy such as prolapse of lumbar intervertebral disc, hyperosteogeny and sciatica, and not only effective catalysis bony spur also effectively reduces painful, can not recur after the healing, pure Chinese medicine ingredients has no side effect, and the gravid woman avoids usefulness, menstrual phase is stopped using, and is the optimum selection medicine of middle-older patient.

Claims (2)

  1. A special for treating hyperosteogeny take medicine, it is characterized in that: this medicine is made by following pharmaceutical composition, each pharmaceutical composition is by weight being made up of following raw material:
    Cortex Eucommiae 15-25 part, Flos Carthami 15-25 part, Caulis seu Radix Schisandrae Henryi 20-30 part, sheep are closed 20-30 part, Radix Isatidis 20-30 part, Radix Aucklandiae 15-25 part, Radix Paeoniae Alba 15-25 part, cattle sunset 15-25 part, Herba Cynomorii 15-25 part, Radix Scrophulariae 15-25 part, Herba Lycopodii 15-25 part, Radix Angelicae Sinensis 15-25 part, Rhizoma Corydalis 15-25 part, Fructus Chaenomelis 20-30 part, Flos Lonicerae 20-30 part, Cortex Phellodendri 15-25 part, Herba Pyrolae 30-40 part, Semen Persicae 15-25 part, Lignum Sappan 15-25 part, Semen Cuscutae 20-30 part, Radix Dipsaci 15-25 part, and adjuvant is pure water 25%-30%; Earlier aforementioned pharmaceutical compositions is ground into smalls, mixes well with water then, make the pill oven dry with machine then, package spare.
  2. 2. according to the medicine of taking of right 1 described a kind of special for treating hyperosteogeny, it is characterized in that: each weight ratio of organizing pharmaceutical composition is as follows:
    20 parts of the Cortexs Eucommiae, 20 parts on Flos Carthami, 25 parts of Caulis seu Radix Schisandrae Henryi, sheep are closed 25 parts, 25 parts of Radix Isatidis, 20 parts of the Radix Aucklandiae, 20 parts of the Radix Paeoniae Albas, 20 parts of cattle sunset, 20 parts of Herba Cynomoriis, 20 parts of Radix Scrophulariaes, 20 parts of Herba Lycopodiis, 20 parts of Radix Angelicae Sinensis, 20 parts of Rhizoma Corydalis, 25 parts of Fructus Chaenomeliss, 25 parts of Flos Lonicerae, 20 parts of Cortex Phellodendris, 35 parts of Herba Pyrolaes, 20 parts in Semen Persicae, 20 parts of Lignum Sappans, 25 parts of Semen Cuscutae, 20 parts of Radix Dipsacis; Adjuvant is a pure water 30%.
CN2010106121389A 2010-12-29 2010-12-29 Oral medicament special for treating osteoproliferation Pending CN102068554A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010106121389A CN102068554A (en) 2010-12-29 2010-12-29 Oral medicament special for treating osteoproliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010106121389A CN102068554A (en) 2010-12-29 2010-12-29 Oral medicament special for treating osteoproliferation

Publications (1)

Publication Number Publication Date
CN102068554A true CN102068554A (en) 2011-05-25

Family

ID=44027433

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010106121389A Pending CN102068554A (en) 2010-12-29 2010-12-29 Oral medicament special for treating osteoproliferation

Country Status (1)

Country Link
CN (1) CN102068554A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105853663A (en) * 2016-04-18 2016-08-17 陈西湖 Traditional Chinese medicine gel paste for treating blood stasis lumbago and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105853663A (en) * 2016-04-18 2016-08-17 陈西湖 Traditional Chinese medicine gel paste for treating blood stasis lumbago and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101559204A (en) Traditional Chinese medicine compound treating irregular menstruation and dysmenorrheal and application thereof in preparing hygienic products of women
CN101433650B (en) Chinese medicinal composition for treating intermenstrual flow and dysmenorrhea
CN101361876B (en) Wound-healing tissue-promoting powder and preparation method thereof
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN1970045B (en) Externally applied Chinese medicine for treating cervical and lumbar spondylosis
CN103393895A (en) Bone-setting traditional Chinese medicine decoction and preparation method thereof
CN101530508B (en) Traditional Chinese medicine for treating ovarian cancer
CN1977936A (en) Chinese medicine compound preparation for treating male-female deficiency syndrome and its preparing method
CN1115165C (en) Externally applied medicated wine for treating traumatic injury and rheumatism
CN102068554A (en) Oral medicament special for treating osteoproliferation
CN101810831B (en) Medicament for treating gynecological diseases
CN102526418B (en) Drug for treating lumbar disc herniation and preparation method thereof
CN102068511A (en) External medicament for treating lumbar vertebral disc protrusion
CN101129718B (en) Traditional Chinese medicine preparation for treating leuoderma
CN103933506A (en) Externally-applied medicament for treating lumbar disc herniation
CN101843825B (en) Chinese medicament for treating climacteric syndromes
CN102430026A (en) Medicine for removing macula
CN102274418A (en) Medicinal powder for preventing and treating anemofrigid cold of livestock and poultry
CN101843759B (en) Oral Chinese medicament for treating fracture
CN101695534B (en) Chinese patent medicament for treating mammary gland disease
CN101721478B (en) Medicine for treating infantile diarrhea
CN101897857A (en) Traditional Chinese medicine pill for curing lumbago
CN101757530A (en) Plaster for treating diabetes mellitus of spleen deficiency type
CN101843768B (en) Chinese medicament for treating climacteric syndromes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20110525